Clinical Trial

Oral Supplementation With a Formulation Based on Cetylated Fatty Acids for Post-fracture Long Bone Healing

Study acronym: CETIULTRA-BONE
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 23, 2025 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
This clinical study aims to evaluate the potential benefits of a formulation based on Cetylated Fatty Acids in improving fracture healing of long bones in the lower limbs. The investigational product is administered orally over a 12-week period. Study procedures are limited to standard imaging techniques (radiography and echography), blood sampling, and completion of validated quality of life questionnaires.
Trial Details
NCT Number NCT07299851
Lead Sponsor Pharmanutra S.p.a.
Collaborators: Artialis
Conditions Fracture Femur, Fracture Tibia
Enrollment 100 participants
Start Date 2025-10-01
Primary Completion 2026-05 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2025-12-23